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In a study conducted at the University of Pittsburgh, 35 female rhesus monkeys were
exposed to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an
effort to establish a plausible animal model for Parkinson’s disease progression and treat-
ment using neurotrophic factors. In addition to standard clinical measurements of Parkin-
son’s severity, actigraphy devices recording minute level activity were fit to each of the
monkeys. This thesis primarily aims to understand how activity patterns in healthy sub-
jects can predict their susceptibility to developing Parkinson’s-like symptoms as a result
of MPTP exposure. Secondarily, we show how subjects respond to neurotrophic factors
in terms of both subjects’ activity and through standard clinical metrics.
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Parkinson’s disease is a chronic, progressive and ultimately debilitating neurological dis-
ease. Currently, treatments are limited to slowing disease progression and reducing the
physical/neurological symptoms of the disease (Dutta et. al, 2013). The disease pro-
gresses as a result of the death of dopinergic neurons (Kong et. al 2015). Establishing
which populations are at highest risk for developing Parkinson’s disease (i.e. at risk pop-
ulations) is an area of ongoing research. It is believed that exposure to environmental
toxins play a key role in risk for developing Parkinson’s disease. Specifically, the neu-
rotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) has been shown to cause
the onset of permanent Parkinson’s symptoms in humans. The suspected cause for the
onset of Parkinson’s symptoms is the destruction of dopaminergic neurons resulting from
the exposure (injection) of MPTP (Burns, 1983; Chassiah et. al, 2001).
Given that the destruction of the dopaminergic neurons is believed to be responsible
for the onset of Parkinson’s symptoms, neurotrophic factors that protect the dopamin-
ergic neurons have potential as therapeutic treatments for slowing the process of neu-
rological degradation and thus disease progression in Parkinson’s patients (Yue et. al,
2013). One measurement that is highly correlated with severity of Parkinson’s symptoms
is overall activity (lower activity is highly associated with more severe disease symptoms)
(Gomez-Mancilla et. al, 1993). To assess the protective benefits of several neurotrophic
factors (NTF), a study at the University of Pittsburgh was conducted involving the
sequential administration of MPTP and NTF in rhesus monkeys.
1
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1.2 Data
This particular study involved 35 female rhesus monkeys observed over three distinct time
periods: at baseline (2 weeks), 3-6 weeks after MPTP administration and 1-6 weeks after
neurotrophic factor administration. For the purposes of this manuscript, we have assigned
these monkeys arbitrary identification (ID) numbers 1-35. Throughout each of these
phases, the monkeys wore accelerometers, providing minute level actigraphy data (1440
measurements per day per monkey). In addition to the activity measurements, the data
contains Parkinson’s severity scores for (most of) the monkeys. This severity score was
assessed both after MPTP and after three rounds of neurotrophic factor administration.
Hereafter, the severity score will be referred to as rating scale or rating score.
Not all 35 monkeys participated in the NTF phase of the study. Two monkeys were
excluded as a result of an overly strong strong negative response to MPTP (one of which
required additional therapies to stay alive following MPTP administration). Three mon-
keys were excluded due to a lack of clinical response to MPTP as measured by the rating
scale. As a result, it was determined that NTF administration was inappropriate for
these monkeys. Those monkeys that participated in the NTF portion of the experiment
were given three infusions of NTF (or a placebo surgery). Each infusion was a major
surgical procedure, and as such there are expected recovery times for activity following
each infusion.
A number of days of activity data were excluded from the final activity data set. The
reason for exclusion of days was usually related to data quality. That is, the device was
found to have been malfunctioning or not working on a particular day/set of days. With
the exception of malfunctions, monkeys wore the same accelerometer in each phase of
the study.
Monkeys chosen for inclusion in the study were all approximately 17 years of age (life
2
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span ≈ 25 years) at the start of the study. Additionally, all monkeys chosen exhibited
no obvious symptoms of Parkinson’s disease at entry.
1.3 Objectives
The main objectives of this analysis are to answer the following questions:
• Response to MPTP (Onset of Disease Symptoms):
– Is there an observed response to MPTP (reflected in change in activity pat-
terns) in rhesus monkeys?
– Does average activity level at baseline predict response to MPTP?
– Are there any other activity measures that can predict response to MPTP?
• Neurotrophic Factor (NTF) Infusion Effect (Recovery):
– Does the administration of any NTF result in an improvement in rating scale?
– Does the administration of any NTF result in an increase in average activity?
The analysis that addresses each of the objectives mentioned above (and the remain-
der of this document) is organized as follows: Exploratory data analysis (Chapter 2),
analysis of monkey response to MPTP (Chapter 3), analysis of monkey response to NTF




As mentioned previously, the device used in this study provides a single ‘activity count’
for every minute of the day. This minute level count is determined using an algorithm that
summarizes the raw tri-axial acceleration data over a sixty second window. One concern
when using these types of devices is that of positioning. That is, different locations on
the body will be subject to different magnitudes of acceleration for the same type of
activity. This concern is especially relevant in wrist-worn accelerometer studies (Bai et.
al, 2014). In this study, monkeys had the devices placed around their necks and were
reasonably secure in their placement (not much room to rotate around the neck). This
placement is reasonably predicted to reduce variation in the magnitude of acceleration
for the same activity and allow for more comparable activity summaries across monkeys.
A further crucial (and often overlooked) assumption in comparing activity numbers
between monkeys is that activity counts across all devices are comparable. That is, will
the same type of movement will result in exactly the same number of activity counts
for any two randomly selected devices (Stephen & Spiro, 2001)? Although testing this
assumption is beyond the scope of this analysis, the study used the same device within
monkeys to the extent possible. As a result, the assumption that activity counts are con-
sistent at least within individual monkeys seems reasonable. Furthermore, considering all
devices were of the same make/manufacturer, activity counts should also be comparable
between monkeys.
Structurally, one feature common to human and monkey activity count data is the
4
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high degree of skewness of activity counts. In this data, the majority of activity counts
are close to 0 (median activity count across all days and phases is 0, 3rd quartile is 11),
while some are quite high (maximum observed minute level activity count is 27,130).
Correspondingly, the distribution of daily average counts per minute is heavily right
skewed. It is therefore common practice in the analysis of count actigraphy data to use
the transformation: log(1+counts/minute) rather than the raw data (Schrack et. al,
2013; Steeves et. al, 2014).
Applying the log transformation to the monkey activity data results in a much more
symmetric distribution of daily average counts/minute. Figure 2.1 shows the change in
distribution of daily average activity counts post log transformation. The histogram on
the right (log transformed counts) exhibits meaningfully less skew than the histogram
on the left (raw average daily counts per minute). As a result, we can more reasonably
apply statistical tests that rely on the normality assumption to compare the transformed
activity counts. To be precise, let yijk be minute level activity for monkey i, day j and
minute k. Additionally, define ỹijk = log (1 + yijk) We can define the following quantities:
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Another prominent feature of this data is missingness at the day level. Table 2.1 lists
the number of days for which there is data for each monkey during each of the 5 phases
of the experiment. The order of the monkeys is organized by NTF treatment group
assignment. As mentioned previously, 5 monkeys were not included in the NTF portion
of the experiment, and thus were not assigned a treatment group. Correspondingly, there
are 0 days of observations for each of these 5 monkeys during the three infusion phases.
However, there are 0 days of observation for other monkeys during various phases of the
experiment. For example, monkey 5 has 0 days of data during Pre-MPTP, Post-MPTP
and Infusion 3.
In analyzing the data, special attention was paid to missing days as informative
missingness could be problematic. Most of the missing days of data resulted from: pen
changes, equipment (actigraphy device) malfunction or forced sedation for operations
relating to the experiment. That is, within a treatment phase, the missingness does not
depend on a monkey’s behavior/activity/response to treatment. Therefore, it may be
reasonable to assume that the missingness is missing at random.
6
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Table 2.1: Number of Days of Data for Each Phase of Experiment (by NTF Group)
Treatment Group ID PreMPTP PostMPTP Infusion1 Infusion2 Infusion3
150 CDNF 5 0 0 24 1 0
13 14 23 29 25 26
14 14 25 29 26 14
17 14 24 29 25 25
19 15 25 25 26 37
22 15 26 26 25 36
450 CDNF 1 14 19 24 20 23
3 6 24 33 24 22
18 14 24 30 16 25
24 15 19 21 29 30
450 GDNF 2 15 18 26 22 24
6 3 24 12 27 22
12 15 25 29 21 25
23 15 18 25 25 35
35 14 26 0 0 31
N2 20 15 25 16 26 33
26 15 26 25 25 36
27 14 21 22 26 30
28 0 0 0 0 25
30 4 23 23 25 31
31 14 24 34 24 28
N4 15 15 24 21 26 36
25 14 26 34 26 30
32 15 20 30 29 30
33 14 23 27 24 32
34 14 26 27 25 0
Vehicle 8 14 15 29 26 25
11 14 26 29 27 27
16 15 18 20 26 36
29 14 23 0 14 5
Not Assigned 4 14 19 0 0 0
7 4 14 0 0 0
9 14 28 0 0 0
10 14 28 0 0 0
21 14 28 0 0 0
7
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2.2 Visualizing Activity
The first step to analyzing complex activity data is to decide how best to visualize the
data. Considering the structure of the experiment and heterogeneity of missing days, the
most natural way to view the activity data is by considering each of the five phases of
the experiment individually. Here we took three main approaches that will be detailed
in the remainder of this section.
2.2.1 Individual Daily Curves
Activity can be thought of as a smooth process throughout the day, but at the minute
level resolution, the data for an individual day can be quite noisy. To smooth the noisy
data, generalized additive models were fit for each monkey-day using the mgcv package
in R by regressing each day’s log transformed activity counts on a smooth function of
the integers 1:1440 (Wood, 2014). Generalized additive models will be described in more
detail later in this document. Figure 2.2 displays the smoothed daily activity curves
for all monkeys, in all five phases of the experiment. Each row corresponds to a single
monkey while each column represents a phase of the experiment. Within each panel,
different colors indicate different days. Plots with no lines indicate no data is available
for those monkeys during the associated phase (column) of the experiment.
Examination of the first column (baseline) makes clear that in some monkeys, there is
considerable day-to-day variability at baseline. In other monkeys, the smoothed activity
pattern appears relatively consistent across days. Another visible feature observed in the
daily curves of most monkeys at baseline is the bi-modal peaks located close to 10am
(hour 10) and 4pm (hour 16). Furthermore, monkeys generally seem to have relatively
stable sleep patterns (indicated by activity near 0 activity during night times) at baseline
with the exception of monkeys 2, 3, 13, 14, 16.
8
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Looking at the MPTP phase (column 2), there is a decrease in daily activity during
the activity periods for the day in most monkeys. In some monkeys this decrease is quite
dramatic (1, 15, 25, 29). Additionally there appears to be increased nighttime activity
in a number of monkeys. This may indicate a disruption of the natural sleep cycle due
to MPTP administration. There may also be increased variability within/across days
and a potential disruption of the circadian (bi-modal peak) rhythm observed at baseline.
However, due to the clustering of lines in these plots, it is difficult to confidently assert
such a difference exists from visual examination alone.
9
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Figure 2.2: Smoothed Individual Curves
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2.2.2 Individual Average Daily Activity
Although plotting the individual curves provides useful insights into the within/between
monkey variability of activity curves, the sheer volume of visual data makes pattern
recognition challenging. One strategy for reducing the visual complexity is to plot some
daily level summary measure for each monkey in each phase of the experiment. To that
end, Figure 2.3 examines the mean of the log(1+counts/minute), ¯̃yij, for each of the
monkeys in each phase of the experiment. The layout for this figure is similar to that of
Figure 2.2. Here, as with Figure 2.2, columns represent the five phases of the experiment.
Rows, however, divide the monkeys into NTF treatment groups with the last row being
those monkeys who did not receive a treatment assignment as they were not included
in those phases of the experiment. Each line provides the trend for individual monkeys.
Gaps in the lines indicate missing days.
The x-axis indicates the days since the start of the experiment phase. In the case
of ‘PreMPTP’ (baseline) all monkeys start at 0 since this is their observation with no
treatment. As mentioned in Section 1.2, PostMPTP administration, monkeys were given
approximately two weeks to recover before they were fitted with their accelerometer
again. One monkey that was not assigned a treatment group was either not fitted with
an accelerometer until ∼40 days after the surgery or the data quality prior to that day
was inadequate for further analysis. In the NTF Infusion phase, however, monkeys
were generally fitted with their accelerometers shortly following surgery. As such, it is
unsurprising to see in a majority of monkeys a slight upward trend in activity following
the start of each of these phases followed by a leveling out as monkeys recover from the
anesthesia/surgical procedure.
From this figure using just the average daily log(1+counts/minute), it can be seen
that, at the daily level, average overall activity within a day is relatively stable for most
monkeys at baseline. In addition, most have ¯̃y between 1 and 2.5 across the days in this
14
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phase. While that is a relatively wide range, the distribution across treatment groups
looks fairly similar. In the Post-MPTP phase (column 2) it is clear that most monkeys
exhibit at least some decrease in activity. It is not immediately obvious from this figure
how average daily activity changes during the NTF Infusion phases (columns 3-5) of the
experiment with the exception of a few monkeys.
Figure 2.3: Average Daily log(1+counts/minute) Over All Observed Periods
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2.2.3 Smoothed Population Curves
Having looked at two different visualizations for the longitudinal/cross-sectional activ-
ity patterns at the individual level, we turn our attention to population level activity
patterns. To do this, we employ a P-spline (penalized B-spline) bi-variate smooth-
ing technique to smooth across monkeys and days found in the ‘refund’ package in R
(Crainiceanu et. al, 2013; Xiao, 2013). Essentially, a penalized B-spline is a piece-wise
polynomial function that smooths data, but penalizes ‘roughness’ in a way that makes the
curve less jagged. By using this bi-variate smoother, we are able to borrow information
across monkeys and days to create smooth population level activity curves throughout
each phase of the experiment.
The result of this smoothing process is one smooth curve per day. The smoothing
method was applied to each of the phases independently due to the unbalanced nature of
the starting dates for each phase across monkeys. The result is five matrices of dimension
max(nip) × 1440 where i indicates monkey and p indicates phase of experiment. For
instance, the monkey with the most days of observation in the Pre-MPTP phase is 15
days, so the resulting matrix will be 15× 1440. Two approaches taken to plotting these
curves are described below.
First, Figure 2.4, expresses the curves in a format similar to that employed in Fig-
ure 2.2. Each panel represents one phase of the experiment, with the process reading
chronologically from left to right. Each curve is associated with a particular day indicated
by color. Here the difference in overall activity level between Pre-MPTP and Post-MPTP
phases is even more visually apparent than in the previous figures. It is also clear that
at the population level there is relative consistency across days within each of these two
phases with two potential exceptions. Furthermore, the bi-modal peak of daily activity
with modes at approximately 10am (Hour 10) and 4pm (Hour 16) becomes clear. The
magnitude of the peak in the morning also tends to be larger than that in the afternoon
16
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Pre-MPTP.
From the three right most panels in Figure 2.4 corresponding to the NTF infusion
phases, the recovery from anesthesia/surgery can be seen. The orange curves, corre-
sponding the the earliest days in each phase, start low and increase until they seem to
level out. It also looks like there are a few curves in phase 2 associated with the later
days of that phase (color purple) where low average activity is observed. If, however,
we look at the Infusion 2 column of Figure 2.2, we see that for those later days only
a few monkeys are contributing data. Moreover, these monkeys have average activity
lower than the other monkeys. A similar phenomena can explain the one unusually high
daily activity curve in the Pre-MPTP phase (color green). Thus, we must be careful
when interpreting these smoothed curves for days where there are relatively few monkeys
contributing data.
Figure 2.4: Smoothed Daily Activity Curves Over All Monkeys
PreMPTP PostMPTP Infusion1 Infusion2 Infusion3
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Even though Figure 2.4 allows for better visualization of patterns at the population
level, longitudinal trends within phases are difficult to spot. To help with visualizing the
longitudinal changes, heatmaps of the activity were created for each of the five phases
as displayed in Figure 2.5. The Figure is organized into five heatmaps, corresponding to
precisely one of the experiment phases. In each of the plots, the x-axis indicates time of
day 1−1440 minutes from left to right. The y-axis reads days from the start of the phase.
Note that the origin (days=0) starts at the top of each plot rather than at the traditional
17
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bottom. This allows for visual examination of the entire experiment longitudinally by
reading from top to bottom down each of the five heatmaps sequentially.
Again, the drop in activity during the active period of the day comparing Pre-MPTP
and Post-MPTP appears quite large. In addition, monkeys appear to have shorter activ-
ity periods as indicated by the narrower band of non-dark blue colors during the 6am-8pm
(Minutes 360-1200) range. Interestingly, during the NTF infusion phases it appears that
at the population level, the afternoon peak is larger than that of the morning. Suggesting
that either the NTF treatment or residual effects from the MPTP may be affecting not
just overall activity, but also activity patterns.
While there does appear to be some increase in overall activity from Post-MPTP
period through the NTF infusion periods (indicated by more yellow during active peri-
ods), it does not appear to be dramatic with the exception of days 32-38 in the Infusion
3 phase. Referring back to 2.3 it becomes clear that only 2-4 monkeys are providing
information for these days and two of those monkeys have average activity far above the
rest of the monkeys.
18
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Figure 2.5: Heat Map of Actigraphy Data - All Phases
19
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Perform bi-variate smoothing in R
1. Set up the data as presented below (note the data can be set up in a number of ways,
but to make the method clear columns will be referred to by name). Here we will
only show the first 6 columns of the dataframe, but the remaining columns 7 : 1443
will contain the activity counts for minutes 4 : 1440. Each row contains an entire
day of activity data for one monkey (MnkyID), which phase of the experiment the
data is associated with (Infusion) and the associated days since start of that phase
(day). Assume this object is a dataframe called ’data’.
day Infusion MnkyID Minute1 Minute2 Minute3
1 PreMPTP 1 0 0 0
2 PreMPTP 1 0 0 0
3 PreMPTP 1 22 11 0
4 PreMPTP 1 0 0 0
5 PreMPTP 1 0 0 0
2. Execute the following code:
require(refund); require(fields)
## Subset the data for the phase you want to view
tmp <- subset(data,data$Infusion=='PreMPTP')
## get the log(1+counts/minute) in a new matrix
X <- as.matrix(log(1+tmp[,paste('Minute',1:1440,sep='')]))
## n1, n2 are dimensions which to smooth over
n1 <- max(tmp$day); n2 <- 1440
## x, z create the 'covariate' vectors
## indicating where on the grid to estimate
x <- tmp$day/n1 - 1/2/n1; z <- (1:n2)/n2 - 1/2/n2
## apply the smoother
20
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est <- fbps(X,subj=unlist(tmp$MnkyID),covariates=list(x=x,z=z),knots=8)
## extract the unique daily smoothed curves
hat <- est$Yhat[match(1:n1,tmp$day),]
## plot the heatmap (optional)
image.plot(1:n1,1:n2,hat,xlab='Days',ylab='Minutes')
21
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3.1 Change in Mean Activity
The first and most natural question to ask regarding the effect of MPTP on monkey’s




. Figures 2.3, 2.4 and 2.5 suggest that
there is a decrease in overall activity on the magnitude of approximately 1−1.25 on the log
scale during peak activity hours. To quantify this difference, one could, within a monkey,
take average across all days during Pre-MPTP and Post-MPTP phases separately and
perform a paired t-test. A paired t-test is not necessarily the most powerful test as
there is some loss of information when averaging across days within a monkey. One
way to utilize all days of data for all monkeys while respecting the correlation structure
between days within monkeys is to employ Generalized Estimating Equations (GEE).
This method will be described in detail as we will use GEE to create a comprehensive
model of monkeys’ longitudinal activity throughout all phases of the experiment (Laird
& Ware, 1982; Liang & Zeger, 1986).
In addition to population level changes in average activity, it is also of interest to see
which monkeys had significant changes in their daily activity. To answer this question
we use unpaired t-tests for each monkey individually comparing their average daily ac-
tivity (¯̃y) Pre-MPTP to Post-MPTP. A Bonferonni correction is applied to the p-values
resulting from these tests to correct for multiple testing (Dunn, 1961).
22
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3.1.1 Generalized Estimating Equations
When working with repeated measures data (i.e. multiple observations for a single sub-
ject) one usually needs to account for the within subject correlation structure. Typically
this problem occurs in the context of regression. In the case where the outcome (condi-
tioned on individuals) is roughly Gaussian, a solution for the estimating marginal models
proposed by Laird & Waire is to use a two-stage random effects model. Marginal models
refers to the fact that the estimate of the outcome does not depend on the covariate
history for previous time points. That is, marginal models answer the questions relating
to population regression parameters.
The idea is to first model the regression parameters within each individual, and then
model the variation between individuals. We will describe the process using a single
random effect (random intercept). Let α0 be the random intercept, describing monkey’s
different ‘mean’ activity at baseline. Next, let ¯̃yij be the (ni×1) vector of daily average of
log(1+counts/minute) for individual i (where ni is the number of repeated observations
of monkey i). Further, let Xi be the (ni × p) design matrix that links the population
level effects β to yij. The two stage iterative estimating process is described below:
(1) Consider the model: ¯̃yij = αi + βXj + εij where εij ∼ N(0, R) (normally distributed
with mean 0 and covariance matrix R). Given the most recent estimates of α0 and
D, estimate the variance/covariance matrix R and solve for β.
(2) Assume αi ∼ N(0, D) where D is of dimension 1 × 1 (or, more generally, number
of random effects × number of random effects). If there are more than one random
effect, they are usually assumed to be independent. Given the estimate of β from
step (1), update estimates of α0 and D.
Laird & Waire (1986) provide a set of estimating equations used to iteratively update
this process. Although the covariance matrix R may be left fully unspecified, this results
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in a loss of one degree of freedom for each additional pairwise correlation estimated.
Therefore, it is generally used only when the number of repeated measures is small
relative to the number of individuals. Even in situations where it is reasonable to leave
the within subject correlation fully unspecified, the algorithms employed in statistical
software packages may not converge to a solution.
In this case, there are more repeated measures than monkeys and is therefore not fea-
sible to use an unspecified covariance structure. In addition, we believe it is reasonable to
assume an exchangeable correlation for both Pre-MPTP and Post-MPTP phases as we
don’t observe any obvious changes in ordering of average activity for monkeys. Further-
more, assuming a correctly specified mean model, GEE is robust to misspecifications of
within-subject correlation structure and the estimates for β are consistent (Fitzmaurice
et. al, 2011).
Liang & Zeger provided a set of estimating equation procedures (generalized estimat-
ing equations) that extended this framework to the generalized linear model (1986).
These estimating equations have been implemented in R using the package geepack
(Højsgaard et al, 2006; Yan & Fine, 2004; Yan, 2002). We will use this package in
the remainder of the paper whenever we fit a model using GEE.
3.1.2 Average Daily Activity
Utilizing generalized estimating equations and assuming an exchangeable correlation
structure between days within monkeys (Equation 3.1), a statistically significant de-
crease in average daily log(1+counts/minute) was found (95% CI: [-0.825,-0.408]). To
test for changes in average activity level temporally across the day, generalized estimating
equations were again used to examine changes at the hourly level (i.e. 24 tests, one test
for every hour of the day). Adjusting for multiple testing using the Bonferonni correction,
a significant decrease in activity was found for all hours including and between 6am and
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7pm. Table 3.1 contains the adjusted 95% confidence intervals for these hours with red
indicating the difference for that hour is statistically significant.
¯̃yij = αi + βXj + eij (3.1)
Where Xj is a ni × 1 vector with xj = 0 if day j is Pre-MPTP and xj = 1 if day j is
Post-MPTP for monkey i:
αi ∼ N(0, D), eij ∼ N(0, R), R = σ2

1 ρ ρ . . . ρ
ρ 1 ρ . . . ρ
ρ ρ




ρ . . . . . . ρ 1

Table 3.1: Change in Hourly Population Average Activity: This table contains the estimate
and 95% Bonferroni corrected confidence intervals for the change in activity (Post-
MPTP administration - Pre-MPTP administration) averaged at each of the 24
hours of the day. Estimates/hours colored red indicate statistical significance.
Hour 1 Hour 2 Hour 3 Hour 4 Hour 5
-0.01 (-0.14, 0.12) 0.00 (-0.12, 0.12) -0.05 (-0.20, 0.09) 0.03 (-0.05, 0.11) -0.02 (-0.10, 0.06)
Hour 6 Hour 7 Hour 8 Hour 9 Hour 10
0.03 (-0.14, 0.21) -0.87 (-1.55, -0.20) -1.43 (-1.97, -0.89) -1.36 (-1.87, -0.86) -1.27 (-1.72, -0.81)
Hour 11 Hour 12 Hour 13 Hour 14 Hour 15
-1.40 (-1.84, -0.95) -1.30 (-1.68, -0.91) -0.95 (-1.28, -0.61) -0.99 (-1.34, -0.64) -1.13 (-1.43, -0.82)
Hour 16 Hour 17 Hour 18 Hour 19 Hour 20
-1.05 (-1.39, -0.72) -0.99 (-1.31, -0.67) -0.94 (-1.33, -0.56) -0.69 (-1.01, -0.37) -0.23 (-0.50, 0.04)
Hour 21 Hour 22 Hour 23 Hour 24
0.03 (-0.16, 0.21) 0.03 (-0.14, 0.19) 0.04 (-0.07, 0.15) 0.01 (-0.13, 0.15)
To get a continuous estimate of the difference Pre-MPTP to Post-MPTP, a bootstrap
25
3.1. CHANGE IN MEAN ACTIVITY CHAPTER 3. RESPONSE TO MPTP
procedure was employed. By bootstrapping individual monkeys, we were able to obtain
confidence intervals for the average activity curves Pre-MPTP to Post-MPTP as well as
a confidence interval for the difference. The left panel of Figure 3.1 shows the confidence
intervals for the Pre-MPTP and Post-MPTP activity curves while the right plot indicates
the confidence interval for the difference (both point-wise and joint). The joint confidence
interval was obtained by multiplying the point-wise standard errors by the .95 quantile
of the maximum of the standardized absolute difference of observed difference and mean
difference for all time points t ∈ (1, . . . , 1440).
Figure 3.1 and Table 3.1 agree in significance of the difference in activity, but vary
slightly on the width of the confidence intervals. From both the table and the figure,
it is clear the largest difference occurs at approximately 9am, corresponding the the
morning peak. Although monkey activity is slightly higher Post-MPTP during most of
the sleeping hours, this difference is not statistically significant.
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3.1.3 Average Activity for Individual Monkeys
Applying unpaired t-tests for changes in the mean daily activity for individual monkeys,
9 of the 33 monkeys did not show a significant decrease in average daily log activity
counts after adjusting for multiple testing using the Bonferroni correction (3, 4, 6, 9, 10,
19, 23, 30 and 32). Three of these 9 monkeys (4, 9 and 10) were excluded from the NTF
phase of the study. Of the remaining 6 monkeys, 5 had significant decreases in activity
using p-values when not adjusting for multiple testing. Table 3.2 provide the Bonferroni
adjusted 95% confidence intervals for change in average daily log(1+counts/minute) for
each of the 33 monkeys for which we have both Pre-MPTP and Post-MPTP data. Red
confidence intervals indicate a statistically significant difference.
Table 3.2: Subject Change in Daily Average Activity: This table contains the 95% Bonferroni
corrected confidence intervals for the change in activity (Post-MPTP administra-
tion - Pre-MPTP administration) for each of the subjects in the study. Subjects
are identified by their ID numbers. Estimates/IDs colored red indicate statistical
significance.
1 2 3 4 6 7 8
(-1.54,-1.20) (-1.15,-0.12) (-1.34, 0.20) (-0.26, 0.55) (-4.36, 2.50) (-1.60,-0.12) (-0.90,-0.45)
9 10 11 12 13 14 15
(-0.37, 0.29) (-0.24, 0.22) (-1.00,-0.10) (-0.88,-0.11) (-0.85,-0.16) (-0.93,-0.12) (-1.51,-0.77)
16 17 18 19 20 21 22
(-1.71,-0.45) (-0.46,-0.22) (-0.84,-0.63) (-0.51, 0.36) (-1.77,-1.01) (-1.26,-0.74) (-1.41,-0.53)
23 24 25 26 27 29 30
(-0.82, 0.32) (-1.22,-0.18) (-1.33,-0.67) (-1.35,-0.31) (-0.64, 0.00) (-0.77,-0.47) (-1.77, 0.16)
31 32 33 34 35
(-0.56,-0.14) (-0.40, 0.07) (-0.85,-0.47) (-0.59,-0.27) (-0.75,-0.28)
3.1.4 Association of Parkinson’s Rating Scale and Activity
The outcome most recognized for clinical significance in the assessment of severity of
Parkinson’s symptoms is the Parkinson’s rating scale. It is known that activity is as-
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sociated with severity of Parkinson’s symptoms. Moreover, it is known that in humans
increased activity is associated with better long term health outcomes. However, it is
unsettled as to whether activity predicts severity of Parkinson’s symptoms or if activity
is just diminished as a result of the onset of Parkinson’s.
Figure 3.2 plots the activity curves of monkeys dichotomized by the median rat-
ing scale. Those in the upper 50th percentile are those monkeys who responded more
strongly to MPTP (negatively) and can be thought of as being highly sensitive to MPTP.
The left column shows the average activity curves (upper left) and the estimated differ-
ence throughout the day (lower left) with confidence intervals obtained by bootstrapping
monkeys Pre-MPTP. The right column shows the activity and difference Post-MPTP.
Although highly sensitive monkeys have lower daytime activity, this difference is not
significant Pre-MPTP. Post-MPTP administration, however, we do see a significant dif-
ference in average daily activity during the peak activity hours.
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Although we dichotomized the monkeys by rating scale, the metric is thought of as
continuous clinically. As a result, there is no well defined, clinically meaningful cut-off
point for measuring severity. Respecting this structure, the association (correlation) of
rating scale with both average daily log(1+counts/minute) pre-MPTP and post-MPTP
was calculated. Figure 3.3 plots the average daily counts against the Parkinson’s rating
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scale (Pre-MPTP on the left, Post-MPTP on the right). This plot shows that average
activity pre-MPTP (that is, before onset of Parkinson’s symptoms) exhibits only a slight
negative correlation with rating scale (-0.07, p-value=0.707). Once Parkinson’s symptoms
have developed, we do see a significant negative correlation (-0.57, p-value=0.001) with
rating scale.
These results imply that average activity prior to developing Parkinson’s symptoms
(pre-MPTP administration) is not predictive of the severity of Parkinson’s symptoms in
response to MPTP. This lack of association between average overall activity and MPTP
response motivates a more sophisticated analysis of activity patterns.
Figure 3.3: Correlations between Rating Scale and Pre/Post MPTP Average Daily Activity






































3.2 Patterns of Activity
3.2.1 Day-to-Day Standard Deviation in Activity Counts
In analyzing patterns of activity, the investigation is to consider the within monkey
day-to-day standard deviation in log transformed activity counts. Using the high/low
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sensitivity dichotomy presented in the previous subsection, the day-to-day standard de-
viation of log transformed activity counts (averaged at the hourly level) was calculated
for both pre-MPTP and post-MPTP phases of the experiment. Figure 3.4 displays the
distributions for standard deviation of hourly average log activity counts for the two
groups of monkeys. The first row of the plot provides the inner quartile range for the
distribution of standard deviations for each hour of the day. The second row plots the
median of the distribution of standard deviations for each hour of the day. The left
column (both first and second row) refers to the pre-MPTP phase while the right column
explores the post-MPTP phase.
Looking at the left column of Figure 3.4, there does appear to be some differentiation
between the low and high sensitivity groups during the waking hours, with the largest
differences occurring at hours 9, 14 and 18-20. None of these differences, are significant
for α = 0.05 using two sample t-tests. Again, since our dichotomizing of the monkeys is
somewhat arbitrary, the correlation between rating scale and standard deviation (using
pre-MPTP phase activity counts) was calculated. The periods with highest correlation
are hours 15, 20 and 12 (ρ̂ = −0.32,−0.22,−0.21, respectively). These are also the
periods in which the largest differentiation in Figure 3.4 was observed between high and
low sensitivity monkeys. Although these correlations were found not to be significant
using permutation test (α = 0.05), the magnitudes suggest activity patterns may predict
response to MPTP.
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3.2.2 Functional Principal Component Analysis (fPCA)
Having established variability in activity as at least a potential predictor of activity, a
reasonable place to look for more complex patterns is in the functional principal compo-
nents of monkey activity. The reason for this is twofold: first, activity data is functional
data (thus motivating the use of fPCA versus PCA). In general, principal component
analysis allows one to examine high dimensional sources of variability (patterns) sum-
marized in relatively few dimensions. Said differently, the method allows for meaningful
reduction of dimensionality while maintaining focus on the sources of highest variability
in the data. In particular, we are interested in seeing if the dominant circadian patterns
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elicited from the first K principal components are predictive of response to MPTP in
monkeys. Therefore fPCA was performed on the Pre-MPTP actigraphy data only.
Defining fPCA
Adopting the notation described by Ramsay & Silverman (2005), we describe how to
perform traditional principal component analysis using minute level actigraphy data for
multiple subjects over multiple days, Then we describe what differentiates classical PCA
from functional PCA. Imagine there are p covariates (here p = 1440 for every minute in
the day). Arrange the data in an (N ×p) matrix where N is the total number of monkey
days Pre-MPTP. Each row of this matrix corresponds to one day of data for one monkey
and each column represents one minute of data ordered chronologically.
The key idea is to find the linear combination (ξ1) of the p predictors that explains
the maximum amount of variance in the data. The goal is then to find another linear
combination that explains the maximum amount of remaining variance as possible, sub-
ject to the constraint that this next linear combination (ξ2) is orthogonal to the first.
This process is repeated to generate new linear combinations that explain successively
less variance in the data. These ξ are referred to as principal components. Generally just
the first few principal components are used as they usually explain a sufficient percentage
of variation in the data. Moreover, interpretation of higher order principal components
becomes increasingly difficult as their effects are dominated by the preceding principal
components.
The covariance matrix of the demeaned data V = 1
n
X′X can be decomposed as
1
n
VΣ2V′. As such, in practice PCA is performed by first calculating the singular value
decomposition of the demeaned data matrix X = VΣU′ due to computational concerns.
Columns of min(p,N − 1)× p matrix V correspond to a ‘principal component’.
The main distinction between traditional PCA and fPCA is the smoothing of the
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covariance matrix. The rationale for smoothing in fPCA is the belief that true functional
data is smooth. To perform this smoothing, one must first choose a basis function. Since
we can consider this type of activity to be periodic, a natural choice of basis uses Fourier
series of sufficient complexity. Suppose we have a series of V Fourier series denoted
φ(V). Let x(s) be the function measuring daily activity. Assuming x is periodic (daily)
this function can be expanded as a Fourier series with coefficients cV =
∫
xφV : x(s) =∑
V cVφV(s). Ramsay & Silverman describe the following steps to perform Functional
PCA (2005):
(1) The coefficients ci are calculated for every day of monkey activity.
(2) Smooth the covariance matrix of Fourier coefficients ci.
(3) Perform standard PCA on the smoothed covariance matrix.
(4) Apply the same smoothing operation as in step (2) to the eigenvectors resulting from
step (3) and normalize so these vectors are orthonormal.
(5) Compute the principal component function ξ by taking the inner product of the
normalized, smoothed eigenvectors from step (4) y and φ(s).
Results of fPCA
Applying functional principal component analysis to the daily activity pre-MPTP (using
the fda package in R), Figure 4.4 was produced. Here, the x-axis is denominated in
minutes instead of hours. The y-axis measures log(1+counts/minute). These plot shows
the first four harmonics which together explain 81.5% of the variability in the data. The
dashed (+) and (−) lines indicate the effect of a +/ − 2 standard deviations from the
mean principal score loading. Each harmonic can be thought of as defining successively
important features of the daily activity curve in monkeys.
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Figure 3.5: First 4 Harmonics Resulting from fPCA Applied to Pre-MPTP Activity


















































































































































































































































































































































































































































The weightings of PC scores (eigenscores) for the first harmonic can be interpreted
as comparing overall activity during the active hours of the day. This mean shift in the
activity curve accounts for most of the variation in the data (51.9%). Specifically, com-
paring a day weighted highly on the first principal component would have higher average
level of activity than a day less highly weighted. The second harmonic compares activity
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in the morning relative to activity in the afternoon. The third harmonic compares activ-
ity during sleeping hours versus activity during midday. The fourth harmonic compares
monkeys with high activity during the two peak activity hours with monkeys who have
higher activity during the afternoon dip (napping time).
In addition to plotting the components, Figure 3.6 plots the smoothed average activity
profiles of monkey days corresponding to the 0.0-0.1, 0.45-0.55 and 0.9-1.0 quantiles of
the distributions of the eigenscores for the first four principal components. By and
large the activity profiles mimic those seen in Figure 3.5, however the activity profiles
corresponding to the tail quantiles for PC3 and PC4 differ slightly from their patterns
from the plot of the harmonics. This is likely due to the influence of PC1 and PC2.
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Correlations were calculated with both mean and standard deviation of daily prin-
cipal component scores. The results can be seen in Table 3.3 (a). The correlations are
not particularly large nor are they statistically significant. To understand more fully
the associations, each of the means and standard deviations for the first four principal
component scores were plotted. Figure 3.7 shows the standard deviation of the third and
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fourth principal component scores plotted against post-MPTP rating scale. A moder-
ately strong negative association exists between the standard deviation of both principal
component scores and rating scale, if monkeys with rating scale below 2 are excluded. In
fact, these monkeys (4, 9, and 10) were excluded from the NTF infusion portion of the
study based on their lack of response to MPTP. When these monkeys are excluded, the
correlations of rating scale with the standard deviation of principal components 2, 3 and
4 increase considerably and become statistically significant for α = 0.05 (Table 3.3 (b)).
Table 3.3: Correlations between Principal Component Scores (Mean & SD)
(a) Full Data
PC1 PC2 PC3 PC4
Mean Score -0.09 0.14 -0.00 0.21
SD of Score -0.04 -0.17 -0.29 -0.16
(b) Monkeys with Rating > 2
PC1 PC2 PC3 PC4
Mean Score -0.27 0.00 0.00 0.23
SD of Score -0.20 -0.38 -0.47 -0.36
Figure 3.7: Association between Rating Scale and SD of PC Scores
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Performing fPCA in R
Using functions from the fda package, fPCA can be performed quite easily in R. The
steps described above are shown below.
## get just the activity counts and take the log
X <- data[,paste('Minute',1:1440,sep='')]; X <- log(1+X)
## Create the fourier basis with correct period and 11 basis functions
basis <- create.fourier.basis(c(0, 1440), nbasis=11, period=1440)
## Creates smoothing penalty (harmonic)
harmonic_Lfd <- vec2Lfd(c(0,(2*pi/1440)^2,0), c(0, 1440))
## Aggregates basis, smoothing penalty and smoothing parameter
harmonic_fdPar<- fdPar(basis, harmonic_Lfd, lambda=1e5)
## Smooth the covariance matrix and extract the 'fd' object
smoothfd <- smooth.basis((1:1440)-.5, t(as.matrix(X)),basis)$fd
## Perform the fPCA on the smoothed covariance matrix and
## extract the first K=4 harmonics, then plot them
fPCA <- pca.fd(smoothfd, nharm=4, harmonic_fdPar)
plot(fPCA)
39
3.2. PATTERNS OF ACTIVITY CHAPTER 3. RESPONSE TO MPTP
3.2.3 Scalar on Function Regression
So far the methods used to predict response to MPTP shown have been increasingly
complex, taking into account more complicated features of the activity profiles of mon-
keys. To model response to MPTP in a fully functional fashion, we turn back to the
idea of generalized additive models (GAMs) first mentioned in Section 2.2.1. In that
section, generalized additive models with a single smooth term were used to smooth ac-
tivity curves. To show how this is possible, we first need to define generalized additive
models. Using this structure, we can non-parametrically model linear predictors that are
a function of some covariate (x) and time (t).
Defining (f)GAMs
Recall: the generalized linear model assumes that an outcome y is distributed with
some mean µ and variance, such that for some exponential family link function η such
that η(µi) =
∑J
j=1 βjxi. The generalized additive model does not place the parametric
restriction on the association between each predictor (β) and the outcome (Hastie &






Where fj is any smooth function of the J covariates. Note that these functions fj
can be parametric in the generalized additive model. The smoothing of activity profiles
performed in Section 2.2.1 resulted from models defining each day of activity as a 1440×1
response vector regressed on the vector t = 1, 2, . . . , 1440. That is, for every monkey day
we fit the model: log (1 + countst) = f1(t) using the mgcv package. The fitted values
from these models create a smooth activity curve.
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In the mgcv package, the smoothing is done using penalized regression splines. The
idea is to place a ’penalty’ on jaggedness of a curve which can be expressed in terms
of a smoothing parameter λ (Wood, 2006). Consider the simple case where the link
function is the identity function (η(µ) = µ) and there is one smooth predictor s and
one predictor x. The solution to linear regression is often expressed as the set of β
coefficients that satisfies the minimization problem: ||y −Xβ||2. However, by placing
no parametric assumptions on the association between x and y, the solution to the least
squares problem would be to fit a curve that passes through every observed point. In
most instances this would be over-fitting the model and yield little useful inference. One
solution is to fit a smooth curve that places a penalty on the ‘roughness’ of the curve.







or, equivalently ||y−Xβ||2 + λβTSβ
Where S is a matrix of known spline coefficients.





In practice, this is fit using Penalized Iteratively Re-weighted Least Squares (P-IRLS) as
a result of the complexities that arise when estimating a GAM where the link function
is not the identity function. By framing the problem in this fashion, the model fit is
not particularly sensitive to choice of knots so long as the number is sufficiently large
(Ruppert, 2002). Rather, the smoothness of the curve is mostly affected by choice of λ.
The gam function in the mgcv package uses cross validation to choose λ.
41
3.2. PATTERNS OF ACTIVITY CHAPTER 3. RESPONSE TO MPTP
Functional Generalized Additive Models (fGAM)
In order to move from to the functional generalized additive model case, we now assume
that we again have some outcome Yi for subject i and some functional predictor Xi(t), t ∈
1 : 1440. In the situation where the link function is the identity function, McLean et. al
(2012) proposed the following model:
E(Yi|Xi) = θ0 +
∫
t∈1:1440
F (Xi(t), t)dt (3.3)
In effect, this model allows for the outcome to depend on both the level of the predictor
X and the time at which this value is observed. That is, this model allows for the
possibility that high activity at 1:00am has a fundamentally different association with
the outcome than low activity at 1:00am which may in turn have a different effect than
low activity at 11:00pm.
The estimation method proposed by McLean et. al utilizes the mgcv package in R
and employs tensor product smooths of penalized B-splines (2012). Given some spline
bases for activity (BX) and time (BT ) where BX and BT have J,K knots respectively,
















BX{Xi(t)}BT (t)dt can be estimated using numerical integration proce-
dures. In analyzing the data, the effect of different bases on our results was examined.
The three bases explored are as follows: tensor product smooths of P-splines, tensor
product smooths of cubic regression splines, and thin plate splines.
To fit these models, two approaches were used. In the first, the log(1+counts/minute)
for each minute (1, . . . , 1440) was averaged across days during the PreMPTP phase for
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each monkey individually. This results in a vector of average log activity counts for
each minute 1, . . . , 1440 (Xi) for each monkey. The resulting X matrix is of dimension
33×1440. Then, the Parkinson rating scores (Yi) were regressed on these average activity
profile using the gam function. This requires the construction of two additional matrices
indicating to the gam function the time indices as well as the quadrature weights. The
method and its justification is described in the online supplementary materials to McLean
et. al (2012).
The second approach utilized the full range of data available for monkeys. To do
this, the same response vector Y was used (33× 1). However, instead of a regression on
activity averaged across days, each monkey’s activity was placed in ‘wide’ format. This
regression requires construction of time and weight matrices that differ in important ways
from the first approach. Following the presentation of the results is a description of how
to fit these models in R. This approach makes the assumption that days are exchangeable
and, assuming k days for each subject, Equation 3.3 now becomes:
E(Yi|Xi,k) = θ0 +
∫
t∈1:1440
F (Xi,k(t), t)dt (3.5)
Results of fGAM
Figures 3.8 and 3.9 show the results of the two approaches fitted models. Both figures
present the estimated linear predictor, the estimated joint effect of activity and time,
using three different choices of basis: tensor product smooths of P-Spline basis, tensor
product smooths of cubic splines, smooths of thin plate splines.
Figure 3.8 plots the linear predictor for approach 1 (mean activity profiles) while
Figure 3.9 plots the linear predictor for approach 2 (using all days). These plots can be
interpreted as follows: consider a single day of activity curve for one monkey. If that curve
were plotted on the (x, y) coordinates of these heatmaps, at each point there would be
43
3.2. PATTERNS OF ACTIVITY CHAPTER 3. RESPONSE TO MPTP
an associated value of the linear predictor Zx,t (indicated by color intensity). The mean
of these values amounts to the ‘effect’ of the linear predictor for that monkey curve.
The addition of this term and the model predicted intercept is equal to the predicted
response.
From both figures, we see that employing tensor product smooths of either P-splines
or cubic splines results in a similar linear predictor. These plots indicate that lower
activity early in the day and higher activity later in the day are associated with lower
Parkinson’s rating scales.
These results are in line with the prior results showing negative correlation with
variability in average activity for hours 12, 15 and 20. That is, monkeys that occasionally
either didn’t nap midday or stayed active until later in the day would have lower predicted
rating scores using these models. Additionally, activity at or near the average activity
levels during the late morning/midday provide little to no information about the rating
scale, in line with the previous findings regarding average activity.
Figure 3.8: fGAM Estimated Linear Predictor Using Mean Activity Profiles
Tensor Product B−Splines With Roughness Penalty
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Figure 3.9: fGAM Estimated Linear Predictor Using All Days
Tensor Product B−Splines With Roughness Penalty
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Using thin plate regression splines to estimate the surface yields a plane that is es-
sentially flat in the time direction. Interestingly, when we estimate rating scale using
all days of activity, the predictions reduce to exactly the predictions made by the linear
regression of rating scale on daily average activity (Table 3.4).
More than likely this is a result of scaling, since thin plate splines can are sensitive to
scale while the tensor product smooths utilized in the gam function are scale invariant.
For our estimation, we re-scaled time to be between 0 and 1. As a result, the effect of
activity completely dominates when using thin plate regression splines. Note that using
properly scaled covariates, thin plate regression splines have been shown to have some
desirable properties. Although this thesis does not explore the effect scaling might have
on the results, that could be a future application.
Lastly, It’s important to remember when evaluating these plots that not all points
on the grid are well populated. For instance, there are very few observations of activity
greater than four log(1+counts/minute) before 3am. Estimates outside this range are
then necessarily extrapolations beyond the observed data. Also, note that within each
figure, the color intensity scales are the same except for the thin plate spline plot.
The question then becomes: what do we gain using these increasingly complex models
of activity to predict Parkinson’s outcomes? To answer that question, the sum of squared
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residuals (SSR) for multiple models was calculated. The SSRs are displayed in Table 3.4.
From this table, we see that there is an improvement in MSE over linear regression (1) in
every model except fGAM using thin plate splines (6) for the reasons stated previously.
Comparing fGAM using the mean activity profiles (2/3), to the fGAM models using all
days of data (5/6), we see a sizable improvement in MSE.
Ultimately, a linear regression of Parkinson’s rating scale on the standard deviation
of the third principal component scores (8) actually performs the best in terms of SSR.
However, the SSR for this model and models (5) and (6) are roughly comparable. Impor-
tantly, the difference in predictive power for fGAM models using all days versus using the
average daily profile further supports the notion that there is more signal present in the
variation between days than in average activity. Despite this improvement in SSR, none
of the models presented here meet the threshold of statistical significance for α = 0.05.
Table 3.4: Sum of Squared Residuals for All Models
Model Sum of Squared Residuals
(1) Linear Regression on Average Daily Activity 428.47
(2) fGAM Mean Profiles (P-Splines) 422.73
(3) fGAM Mean Profiles (Cubic Splines) 422.73
(4) fGAM Mean Profiles (Thin Plate) 425.64
(5) fGAM All Days (P-Splines) 398.91
(6) fGAM All Days (Cubic Splines) 400.54
(7) fGAM All Days (Thin Plate) 428.47
(8) Linear Regression on SD of PC3 394.39
Simulation Study
As stated previously, it is unclear whether our inability to detect a statistically significant
association between ‘patterns’ of activity and Parkinson’s’ rating score is due to a lack
of power (small sample size) or a true lack of association. To more thoroughly explore
the nature of this problem, a simulation study was performed where the true association
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between activity and outcome was precisely the function estimated using tensor product
smooths of P-splines (Figure 3.9, left panel).
Essentially, daily activity curves were generated from a ‘population average’ activity
curve with noise. The population curve was created using a mixture of normal dis-
tributions and chosen to closely mimic the average population activity curves during
the pre-MPTP phase of this experiment. Six different scenarios were examined using
different number of subjects/monkeys (n = 33, 100), different numbers of days of obser-
vation (J = 1, 10) and different amounts of ‘noise’ added to to the simulated Parkin-
son’s’ scores (σ21 = 2.5, σ
2
2 = 1). For every scenario we examined both in sample Mean
Squared Error (MSE) and out of sample mean squared error predicted on 33 new sub-
jects (MSE = 1
n
∑n
i=1 (ŷ − yi)
2). For the simulations with multiple days of observation,
we also calculated the MSE for predictions using fGAM on the average activity profiles.
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Table 3.5: Quantiles of Activity for One Simulation of 33 Monkeys vs Observed Quantiles
Min 25th Median 75th 90th Max
Observed Activity Data 0.00 0.00 0.00 3.66 5.51 9.99
Randomly Generated Data 0.00 0.00 0.00 3.74 4.96 10.44
In assessing how closely the randomly generated data matches the observed data, a
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number of plots and summary statistics were assessed. The left two panels of Figure 3.10
compares a randomly generated day of activity versus an observed day of activity. The
smoothed curves appear similar in shape and the distribution of activity counts through-
out the day also appear reasonably similar.
Table 3.5 Compares one distribution of activity counts over all days and monkeys
for iteration of the simulation (n = 33) versus the distribution of all observed activity
pre-MPTP. Again, the distributions look quite similar. The right panel of Figure 3.10
compares the distribution of observed outcomes (Parkinson’s’ rating scores) and our
randomly generated outcomes. While the average of the randomly generated outcomes
is higher, the distributions appear fairly similar for the scenario ’Higher Noise’.
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Finally, Figure 3.11 shows the results of the simulation study. The top panel, corre-
sponding to the higher noise model, shows that while in-sample performance is noticeably
better using fGAM compared to linear regression (red vs. green), the out of sample pre-
diction using fGAM is no better (gold vs blue), even though fGAM is the true model.
This is true even with 33 subjects 10 days of observation. Importantly, these simulations
do not propose monkey specific curves and the day-to-day variability within subjects is
considerably lower than in the actual data.
Interestingly, however, in the bottom panel it can be seen that with 100 fGAM per-
forms better out-of-sample than linear regression on the average activity counts. As a
result of decreased noise (increased signal-to-noise ratio), fGAM performs better than
linear regression for the out-of-sample prediction.
These results suggest several possibilities. It may be that there is truly no signal in
activity patterns that predicts response to MPTP well. Alternatively, the signal may be
present, but 33 monkeys may not provide sufficient power to detect the signal consistently
with statistical significance. Future simulations might consider exploring the effect of
monkey specific activity curves and imposing larger day-to-day variability in the activity
counts that may capture more of the complex features of real-world activity data.
Performing fGAM in R
As mentioned previously, to fit fGAM models in R, we make use of the mgcv pack-
age. Both the simple (no repeated days) and the more complex (repeated days) will be
explained. To fit this class of models, the data needs to be structured as follows:
• Y : An n× 1 matrix of responses
• X: An n × J matrix of functional predictor values. For our simple case (models
1/2), this matrix would be 33 × 1440 (xmat.wide : For models (5/6), this matrix
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should be n × 1440× max(number of days)). If not all subjects have the same
number of days of data, missing values should be indicated by 0.
• Tmat: An n×J (tmat.wide: n× max(number of days)) matrix of time indices. For
convenience, we re-scale time to be on the [0, 1] scale, but this is not a requirement.
• L: An n × J (lmat.wide: n × 1440× max(number of days)) matrix of weights.
This matrix should have rows that sum to 1. So, in the simple case, every entry
in the matrix would be 1
1440
. In the scenario where there are multiple days of
observation, each row needs to be 1
1440
×(number of days of observation for that
subject). Crucially, entries corresponding to missing functional covariate values
need to be 0.
library(mgcv)
## fit the single day per subect models
fit <- gam(y~te(X,Tmat,by=L,bs='ps') ,method='REML') ## P-splines
fit2 <- gam(y~te(X,Tmat,by=L),method='REML') ## Cubic regression splines
## fit multiple days models using the same two bases
fit.full <- gam(y~te(xmat.wide,tmat.wide,by=lmat.wide,bs='ps'),method='REML')
fit.full2 <- gam(y~te(xmat.wide,tmat.wide,by=lmat.wide),method='REML')
## Plotting the linear predictors
xind <- seq(0,8,len=100)
tind <- seq(0,1,len=100)
est.full <- predict(fit.full, type="iterms",
newdata=data.frame(xmat.wide=rep(xind, length(tind)),
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4. NTF Infusion Effect
4.1 Posthumous Brain Cell Counts
Following the observation period for infusion 3, the monkeys were sacrificed and insti-
gators performed autopsys. From their examination of the deceased monkeys’ brains,
they determined that only 4 treatment groups seemed to have a nueroprotective effect
using some measure of brain cell count relating to doperminergic neuron function. These
neurotrophic factors were: 150 CDNF, 450 GDNF, N2 and N4. As such, the analysis
that follows will focus specifically on the monkeys in those 4 treatment arms versus the
monkeys that received the vehicle treatment.
4.2 Change in Mean Activity Counts
To assess whether we see a significant treatment effect, we fit the following model 5.1 using
generalized estimating equations. This model allows for testing if there is a difference in
average daily log activity between vehicle and NTF treatment groups during the Infusion
phase(s). This model assumes that the average activity for NTF and vehicle groups are
the same during the MPTP phase adjusted for baseline activity and weight (a test was
performed and found this difference to be insignificant).
Yij = β0 + β1(Baseline)i + β2(Weight)i + β3I(t = 1) + β4I(k = 1) ∗ I(t = 1) (4.1)
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i = Monkey , j = Day
t =
 0 MPTP Period1 NTF Infusion period , k =
 0 NTF Treatment1 Vehicle , cor(Yim, Yin) = ρ,m 6= n
Although we do not show the regression output here, there is neither a significant differ-
ence between the treatment groups during the infusion period, nor is there a significant
difference between the MPTP and treatment periods. However, the direction of the co-
efficients are consistent with the hypothesis that there is a treatment effect.
Given that these are invasive surgeries which take time to recover from, models were also
fit looking at just the Infusion 3 period activity, activity 14 days after the surgical infusion
procedure and a combination of these two conditions. Again, no significant differences
were found between the time periods and the treatment groups. Figure 4.1 shows the
daily average log(1+count/minute) in just the post-MPTP and infusion periods. For
the infusion periods we only consider days more than 2 weeks (14 days) from surgery.
Essentially this is the a subset of Figure 2.3 but at a higher resolution. The figure is
consistent with the results of no treatment effect on average activity levels.
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Figure 4.1: Post-MPTP Vs Lagged Infusion Activity





















































4.3 Change in Rating Scale
Considering the inability to detect a statistically significant difference in mean activity
counts between the treatment/vehicle monkeys, it is of interest whether there is a mea-
surable recovery in the monkeys receiving NTF that is not captured i mean activity.
To that end, the change in Parkinson’s rating scale was assessed using multiple linear
regression. Equation 4.2 explicitly defines the model fit.
∆Rating Scalei = β0 + β1Treatmenti + β2Weighti (4.2)
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Adjusting for weight, those monkeys in the 4 NTF treatment groups of interest have
an expected 2.33 (95% CI: 0.46, 4.21) unit decrease in rating scale compared to the
vehicle group. This difference indicates that the treatments are successful in reducing
the Parkinson’s symptoms associated with MPTP to a degree that is greater than no
treatment. Figure 4.2 shows the distribution of change in rating scale. The left panel
combines all the treatment groups under the label ‘NTF’ while the right panel displays
the distributions for each NTF treatment group and the vehicle. It is clear that the 150
CDNF treatment group showed the largest improvements among all groups, while the
three remaining NTF groups had approximately the same degree of improvement.



























As wearable devices become smaller and less expensive, the use of actigraphy devices
is likely to rapidly increase. Given the wealth of knowledge supporting the benefits of
physical activity to human health, and the known deleterious effects of many chronic
diseases on activity, it is imperative that statistical methods are developed to make
inference from this complex data. Here, an attempt was made to show preliminary
evidence that activity and/or patterns of activity can be used to elicit latent susceptibility
to developing a debilitating disease (Parkinson’s) and help understand aspects of potential
recovery.
5.1 Response to MPTP
From the analysis described above, it can be concluded that indeed, MPTP does signif-
icantly affect average daily activity adversely in rhesus monkeys. However, the level of
activity prior to MPTP administration is not predictive of response to MPTP as mea-
sured by the Parkinson’s rating scale. There is moderate support in the data for the
belief that daily patterns of activity can predict response to MPTP. While this support
does not manifest in statistical significance, the association between ‘activity patterns’
and response to MPTP is stronger than the association with average levels of activity. It
is unclear if this lack of statistical significance is due to a lack of power or a true lack of
signal. Considering the relatively strong predictive power among monkeys that respond
negatively to MPTP (i.e. rating scale ≥ 2), more work needs to be done to determine
if it is possible to predict which monkeys will have a meaningful response to MPTP.
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Then, among those that will respond negatively to MPTP, what measures can predict
the severity of this effect.
5.2 NTF Infusion Effect
A significant improvement in Parkinson’s symptoms was seen as measured using the
Parkinson’s rating scale for at least some of the neurotrophic factors measured. This
improvement in symptoms does not appear to translate into a recovery in average activity.
This could suggest that perhaps the neurotrophic factors would show improved outcomes
in activity given a longer period of observation. Perhaps while the vehicle monkeys would
continue to decline in activity, the neuroprotective effects of the treatments might allow
monkeys to maintain their post-MPTP activity levels for a longer period than they would
have been able to otherwise.
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